about
Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.Role of hormones and blood lipids in the pathogenesis of acne vulgaris in non-obese, non-hirsute females.Hormonal therapies in acne.Acne in hirsute womenEffect of the glycemic index of carbohydrates on Acne vulgarisDiagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome.Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective studyThe role of androgen and androgen receptor in skin-related disorders.A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence.Acne in women.Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.Insulin sensitivity, androgens and isotretinoin therapy in women with severe acne.Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome.High serum dehydroepiandrosterone sulfate is associated with phenotypic acne and a reduced risk of abdominal obesity in women with polycystic ovary syndrome.A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women.Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences.The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne.Acne severity and the Global Acne Grading System in polycystic ovary syndrome.Assessment of androgens in women with adult-onset acne.Colour homogeneity and visual perception of age, health and attractiveness of male facial skin.Evaluation of anti-acne properties of phloretin in vitro and in vivo.Adult-onset acne: prevalence, impact, and management challenges.Acne in adult women: epidemiological, diagnostic and therapeutic aspects.
P2860
Q34550578-245154D6-D4E6-4D1C-AC12-E24CE0F1D100Q34616910-30807BDD-D011-46D9-B8F5-63C07A2F46DBQ34706886-D7E94562-6FDD-4EDA-AC06-665C36E1719AQ34945922-DA0C050D-3FF5-4075-B29F-3A571F32F562Q35670832-6FCE9D0E-8B77-4739-A618-D400CE2D222BQ36605428-815604F2-D279-4BFD-A5C5-6A6D4724AC07Q36947205-0FA92F2C-0640-4FD8-A3D8-CA1879A3F55EQ37149457-9FC4C254-7088-49E3-ADA1-7B87316D81CDQ37973246-468AD081-6F72-4AA1-A645-BF0B042410AAQ38322319-1A298A9E-3D13-4849-B7AF-ACE29C6EB6E2Q42464864-0E284E03-07FD-4FED-BE2B-D1878C1191AEQ42974919-41B88909-33FD-4DC4-A752-95FE97829F93Q43481054-B8ED12AE-71DC-4C6D-914F-30469A2E2A90Q43545033-E7DFDB5E-5478-4480-940E-296CAF94584BQ43591076-12EF7797-1A2A-4489-8C78-5AE975A4F1D1Q44086641-B05361F8-8869-41C5-AC72-BAE73DB5E9BAQ44191652-E27DC7DF-079B-4280-B936-010E7BE2F9D0Q44192904-BD4E9137-0448-4820-80AB-6C11121F07F6Q45195258-9D78D83E-5A30-4460-B113-B7CE90E177C2Q46910793-84069F39-E66D-4751-A3C5-D7F84F478B64Q47253419-007E977F-12F2-4691-A28B-578AF2BBB962Q48154221-A23AE12A-ACFD-4954-984E-BE9EBC3BFA77Q49228254-5A5B04A7-038D-4148-A275-CB1EA85AD1EBQ51506212-9D003598-1FD9-4BE8-8492-03657DF7D666
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Hyperandrogenemia in patients presenting with acne.
@en
Hyperandrogenemia in patients presenting with acne.
@nl
type
label
Hyperandrogenemia in patients presenting with acne.
@en
Hyperandrogenemia in patients presenting with acne.
@nl
prefLabel
Hyperandrogenemia in patients presenting with acne.
@en
Hyperandrogenemia in patients presenting with acne.
@nl
P2093
P1476
Hyperandrogenemia in patients presenting with acne.
@en
P2093
P304
P356
10.1016/S0015-0282(01)01701-0
P407
P577
2001-05-01T00:00:00Z